NCT05229055 is a Phase 2, PHASE3 clinical trial of Ketamine in Acute Pain, sponsored by University of Monastir.

Who is sponsoring NCT05229055?

NCT05229055 is sponsored by University of Monastir.

What drugs are being tested in NCT05229055?

Interventions in NCT05229055: Ketamine.

What condition does NCT05229055 study?

NCT05229055 studies Acute Pain.

Is NCT05229055 still recruiting?

NCT05229055 is currently status unknown. Last updated 15 May 2023.

Last reviewed 2023-05-15 · How we verify

NCT05229055

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )

Status unknown Phase 2, PHASE3 Last updated 15 May 2023

What this trial tests

Phase 2, PHASE3 trial testing Ketamine in Acute Pain in 1,000 participants. Status unknown.

Timeline

15 April 2023

Primary endpoint
30 May 2024

1 December 2025

Quick facts

Lead sponsor	University of Monastir
Phase	Phase 2, PHASE3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	1,000
Start date	15 April 2023
Primary completion	30 May 2024
Estimated completion	1 December 2025
Sites	1 location across Tunisia

Drugs / interventions tested

Ketamine (ketamine) — full drug profile →

Conditions studied

Acute Pain — all drugs for Acute Pain →

Sponsor

University of Monastir

Who can join

Adults 18 to 60, any sex, with Acute Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pain is the most common complaint for emergency department (ED) visit. Intranasal ketamine has been shown to provide rapid, well-tolerated, effective analgesia to emergency department (ED) patients with acute pain. few trials have studied ketamine infusion subcutaneously for pain management in trauma patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ketamine

Trials testing the same drug.

NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
NCT06963294 — Ketamine and Dexmedetomidine for Delirium in Joint Arthroplasty · NA · not yet recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07197684 — Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surg · NA · not yet recruiting
NCT06231563 — Ketamine for Veterans With Parkinson's Disease · Phase 2 · recruiting

Other recruiting trials for Acute Pain

Currently open trials in the same condition.

NCT06779604 — Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery · recruiting
NCT07348419 — Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery · NA · recruiting
NCT07335159 — Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention · NA · recruiting
NCT07348523 — Comparison of the Postoperative Analgesic Efficacy of Classical and Modified Erector Spinae Plane Blocks After Lumbar Sp · NA · recruiting
NCT07336264 — Characterization of Acute Pain · recruiting

Other University of Monastir trials

Trials by the same sponsor.

NCT07345156 — Congestion and LActate at diScHarge in Acute Heart Failure · not yet recruiting
NCT07181642 — Diaphragmatic Breathing for Sleep Bruxism in Adults: A Randomized Controlled Trial · NA · completed
NCT06980727 — Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED · Phase 3 · not yet recruiting
NCT06900972 — Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial · Phase 3 · enrolling by invitation
NCT06723002 — Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05229055 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Monastir
Last refreshed: 15 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05229055.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing